You are here

  • Home
  • Archive
  • Volume 5, Issue 3
  • Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Article metrics

Article menu
XML
Infectious diseases
Protocol
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

 

Online download statistics by month:

Online download statistics by month: January 2018 to January 2023

AbstractFullPdf
Jan 201857495
Feb 201860489
Mar 2018705831
Apr 201830306
May 201840367
Jun 201844388
Jul 201840409
Aug 2018424211
Sep 2018333310
Oct 2018959518
Nov 2018646416
Dec 201829298
Jan 2019303015
Feb 2019292811
Mar 2019363614
Apr 2019413916
May 2019353513
Jun 2019434323
Jul 2019503713
Aug 2019725218
Oct 2019534310
Nov 2019403016
Dec 2019604824
Jan 2020524411
Feb 202032309
Mar 2020494910
May 2020454513
Jun 2020272514
Jul 2020433113
Aug 2020483520
Sep 2020543924
Oct 2020654727
Nov 2020433011
Dec 2020312820
Jan 2021342721
Feb 202117119
Mar 2021442615
Apr 2021543918
May 2021413019
Jun 202116166
Jul 2021212214
Aug 2021202014
Sep 2021363527
Oct 2021534332
Nov 2021211223
Dec 2021282715
Jan 2022281911
Feb 2022161317
Mar 2022514418
Apr 202259509
May 2022443624
Jun 2022252112
Jul 20222176
Aug 202230219
Sep 2022171316
Oct 202221199
Nov 2022262412
Dec 202216157
Jan 2023221317
Total23431989863